HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Over The Counter 25 Apr 2022: Exploring The Intersection Of Skin Care, AI And Business With Revieve's Sampo Parkkinen

Executive Summary

In this episode of Over The Counter, HBW Insight speaks to AI technology expert Sampo Parkkinen, CEO of Revieve, which helps its clients deliver personalized digital brand experiences. We discuss the importance of customization for businesses and consumers, the future of AI in the cosmetics industry, and the younger demographics that are most interested in brand personalization. Parkkinen also comments on Revieve’s space in the metaverse, and how businesses can leverage new technology to build relationships with consumers.

Further Reading

Unilever’s Living Proof To Provide First Look At Revieve AI Haircare Advisor

Beauty In The Metaverse: Top Companies Move To Fence Off IP With Eyes On Seminal Court Cases

Artificial Intelligence In Consumer Health: Reality, Challenge And Opportunity

HBW Insight’s Key Takeaways From 2021: #3 Keep Your Eye On AI

Further Listening

These and all other podcasts are available on the Informa Pharma Intelligence channel on Apple PodcastsGoogle PodcastsSoundCloud and TuneIn - and also now on Spotify Podcasts - and via smart speakers if one of these platforms has been set up as your default podcast provider. 

Over The Counter Theme Music:

Modern Chillout by penguinmusic

Copyright 2021 Licensed under a commercial Pixabay License.

 

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

RS152445

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel